Despite remarkable advances in antiarrhythmic drugs, ablation procedures, and stroke-prevention strategies, atrial fibrillation (AF) remains an important cause of death and disability in middle-aged ...
Recent experience with several high-profile drugs demonstrates the great challenges in developing effective and safe therapeutics. A complementary approach to the popular paradigm of disease genetics ...
AMSTERDAM--(BUSINESS WIRE)--Scenic Biotech, a pioneer in the discovery of genetic modifiers developing therapeutics to treat severe diseases, today announced that it has entered into a Cooperative ...
On January 1, 2015, the Centers for Medicare & Medicaid Service (CMS) introduced 4 Healthcare Common Procedure Coding System modifiers, known collectively as the - X(EPSU) modifiers, as a subset of ...
VISBEK, Germany, Oct. 18, 2021 /PRNewswire/ -- EW Nutrition announces the launch of a best-in-class next generation gut health modifier. Ventar D is an innovative proprietary blend of phytomolecules ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results